Purpose
Oral nutrition is considered primary therapy for dry eyes and meibomian gland dysfunction. The purpose of this study was to assess the effect of oral re-esterified omega-3 fatty acids on tear osmolarity. MMP-9, OSDI, tear break-up time (TBUT), Schirmer’s score, corneal staining and omega index.
Methods
This was a multicenter, prospective, interventional, placebo controlled, double masked, randomized trial. On final analysis, 105 patients with dry eyes were randomized to receive four capsules (2 gm) once a day containing 1680 mg EPA and 560 mg DHA (PRN Dry Eye Omega Benefits) for 3 months or four capsules of placebo. All patients underwent a screening, baseline, 6 week and 12 weeks visit. On each visit patients were tested for tear osmolarity, MMP-9, fluorescein corneal staining, Schirmer’s testing, and OSDI. On the screening exam and week 12 evaluation patients had their omega index tested.
Results
Mean tear osmolarity at baseline, week 6 and week 12 was 326.0+15.4, 317.0+20.5 and 317.7+19.7 mOsm/L for the placebo group versus 326.2+15.8, 309.4+13.4, 306.9+12.1 mOsm/L for the omega-3 group (P=0.042 Week 6; 0.004 Week 12) OSDI placebo group at baseline, week 6 and 12 was, 27.1±22.9, 19.6±17.0, and 22.0+19.3 compared to 32.4±19.2, 21±14.4, and 15.5+11.0 for the omega group. (P=0.285 Week 6; 0.002 Week 12) Tear break-up time placebo group at baseline, week 6 and 12 was 4.61±2.04, 5.55±2.43 and 5.81+3.13 compared to 4.78±2.96, 6.64±3.17 and 8.25+4.78 for the omega group. (P=0.126 Week 6; 0.002 Week 12) Omega index levels statistically improved at 12 weeks in the omega group vs placebo (p<0.001).
Conclusion
This study demonstrated that oral consumption of re-esterified omega-3 fatty acids (1680 mg EPA and 560 mg DHA once daily for 12 weeks) is an effective treatment of dry eyes and results in a statistically significant improvement in tear osmolarity, OSDI, tear break-up time and omega index levels.
Clinical Trial Results
- Significant improvement in tear osmolarity
- Significant improvement in omega-3 index levels
- Significant improvement in OSDI
- Significant improvement in tear break-up time
Contact Us
If you have more questions about LASIK procedures, get in touch with us.
Related Blogs

Understanding the Role of Digital Mapping in LASIK Success
Digital corneal mapping combines topography, tomography, wavefront aberrometry, and epithelial‑thickness analysis to produce a three‑dimensional, high‑resolution model of the eye’s optical system. By measuring curvature,

The Impact of Advanced Laser Technology on Post‑Operative Comfort
Advanced laser technology is the cornerstone of today’s refractive surgery. Femtosecond and excimer lasers now create corneal flaps and stromal reshaping with micron‑level accuracy, which

The Latest Breakthroughs in EVO ICL Implant Technology
The EVO ICL (Implantable Collamer Lens) is a flexible intra‑ocular lens placed behind the iris and in front of crystalline lens. Made from Collamer—a biocompatible